Vineet Laboratories Announces Newspaper Publication for Rights Issue

Vineet Laboratories Limited has announced the publication of newspaper advertisements regarding its Rights Issue of fully paid-up Equity Shares. This publication is in accordance with Regulation 84 of...

Vineet Laboratories Limited has announced the publication of newspaper advertisements regarding its Rights Issue of fully paid-up Equity Shares. This publication is in accordance with Regulation 84 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements), 2018 (“SEBI ICDR Regulations”). The advertisements, published on December 29, 2025, disclose the completion of the dispatch of the “Letter of Offer” and “Composite Application Forms”. These were issued in relation to the outcome of the Rights Issue Committee meeting held on December 17, 2025. The newspaper advertisements appeared in all editions of the Financial Express (English), Jansatta (Hindi), and Nava Telangana (Telugu), the regional language of Telangana where the company's registered office is located. The Rights Issue involves up to 99,87,258 fully paid-up Equity Shares of face value ₹10 each, offered at a price of ₹30 per share (including a premium of ₹20). The issue is on a rights basis to eligible equity shareholders in the ratio of 13 Rights Equity Shares for every 12 fully paid-up Equity Shares held as of the record date, December 23, 2025. The total issue aggregates up to ₹29,96,17,740. The dispatch of the Letter of Offer and Application Forms to eligible equity shareholders was completed on December 24, 2025. The issue closing date for applications is January 21, 2026, though the board may extend this period. The on-market renunciation period for rights entitlements is from January 01, 2026, to January 16, 2026.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Vineet Laboratories Limited in the news today?

Vineet Laboratories Limited (VINEETLAB) is in the news due to the announcement is a routine regulatory filing regarding the publication of advertisements for an ongoing rights issue. it does not contain any new financial performance information or significant business developments that would influence sentiment.

Rights IssueOther Regulatory Filings
Vineet Laboratories LimitedVINEETLABhttps://prysm.fi/v2/analyze/VINEETLAB

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Vineet Laboratories Announces Newspaper Publication for Rights Issue

December 29, 2025, 08:16 AM

AI Sentiment Analysis

Top Queries to Ask About Vineet Laboratories Limited

Vineet Laboratories Limited has announced the publication of newspaper advertisements regarding its Rights Issue of fully paid-up Equity Shares. This publication is in accordance with Regulation 84 of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements), 2018 (“SEBI ICDR Regulations”).

The advertisements, published on December 29, 2025, disclose the completion of the dispatch of the “Letter of Offer” and “Composite Application Forms”. These were issued in relation to the outcome of the Rights Issue Committee meeting held on December 17, 2025.

The newspaper advertisements appeared in all editions of the Financial Express (English), Jansatta (Hindi), and Nava Telangana (Telugu), the regional language of Telangana where the company's registered office is located.

The Rights Issue involves up to 99,87,258 fully paid-up Equity Shares of face value ₹10 each, offered at a price of ₹30 per share (including a premium of ₹20). The issue is on a rights basis to eligible equity shareholders in the ratio of 13 Rights Equity Shares for every 12 fully paid-up Equity Shares held as of the record date, December 23, 2025. The total issue aggregates up to ₹29,96,17,740.

The dispatch of the Letter of Offer and Application Forms to eligible equity shareholders was completed on December 24, 2025. The issue closing date for applications is January 21, 2026, though the board may extend this period. The on-market renunciation period for rights entitlements is from January 01, 2026, to January 16, 2026.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Vineet Laboratories Limited

Discover more trending news on Prysm

View All